Anti-CCDC134 antibodies are used in the immunodetection of the protein coiled-coil domain containing 134. In humans, the canonical protein has a reported length of 229 amino acid residues and a mass of 26.6 kDa. Its subcellular localization is in the nucleus, ER, cytoplasm, and is secreted. It is notably widely expressed in many tissue types. A member of the CCDC134 protein family, CCDC134 is known to be involved with angiogenesis and placenta development. Post-translational modifications have been described, including O-glycosylation. The CCDC134 gene has been associated with the disease, Osteogenesis imperfecta. Synonyms for this target antigen include coiled-coil domain-containing protein 134. CCDC134 gene orthologs have been reported in the mouse, rat, bovine, frog, chimpanzee and chicken species. Western Blot is the most common application for the CCDC134 antibodies listed below. ELISA, Immunofluorescence, and Immunohistochemistry are also common applications.